MYO1G and acute lymphoblastic leukemia: In this study, we generated monoclonal antibodies against human Myo1g, and demonstrated that the three of them could recognize the endogenous protein in normal and transformed B and T cells, and evaluated their potential use in recognizing the overexpression of Myo1g in blood samples from pediatric ALL patients as a putative biomarker.